Pituitary apoplexy after somatostatin analogue administration: coincidental or causative?
- 1 October 2013
- journal article
- letter
- Published by Wiley in Clinical Endocrinology
- Vol. 81 (3) , 471-473
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Frequency of Pituitary Tumor Apoplexy During Treatment of Prolactinomas with Dopamine Agonists: A Systematic ReviewCNS & Neurological Disorders - Drug Targets, 2013
- Pituitary Apoplexy After a Single Dose of Long-Acting OctreotideThe Endocrinologist, 2010
- Analytic Review: Pituitary Tumor Apoplexy: A ReviewJournal of Intensive Care Medicine, 2008
- Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centreEuropean Journal of Endocrinology, 2001
- Somatotropinoma Infarction During Octreotide Therapy Leading to Bilateral Cavernous Sinus SyndromePituitary, 2000